Skip to main content

Table 2 In vivo follow up of transduced cells in blood. Absolute number of transduced cells per 106 PBMCs were evaluated by semiquantitative PCR amplification of IFN-β transgene in the two groups of animals. For in vivo f ollow up of transduced cells in blood from macaques, DNA samples of PBMCs were obtained at different dates following infusion of transduced PBL. This table indicates the minimum and maximum number of days following the first infusion of transduced cells in which the construct used was still detectable in PBMCs. Moreover, maximum transduction rate of PBMCs and detection treshold of the PCR method are indicated in the two groups of animals. IFN group is represented by the three macaques that received their own cells transduced by the biologically active construct of IFN-β gene whereas the control group is represented by the three macaques that received their own cells transduced by the control one. The relative intensity of the signals was compared to serial dilutions of lysate derived from plasmid-transfected cells that contained known numbers of IFN-β transgene copy per cell. a Day 0 is the first infusion day, other infusions occured at days 361 and 613. b Absolute number of transduced cells was below 10 per 106 PBMCs.

From: Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251

  

1st infusiona

Days post-1st infusion

0

1

4

8

12

14

20

22

25

29

33

52

64

81

95

IFN

IFN1

NDb

10

10

10

10

10

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

 

IFN2

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

NDb

 

IFN3

NDb

10

10

10

10

10

10

10

10

10

NDb

NDb

NDb

NDb

NDb

Control

C1

NDb

10

10

1000

100

10

10

10

10

10

NDb

NDb

NDb

NDb

NDb

 

C2

NDb

10

10

10

10

10

10

10

10

10

NDb

NDb

NDb

NDb

NDb

 

C3

NDb

10

700

10

10

10

10

10

10

10

NDb

NDb

NDb

NDb

NDb

  

2nd infusiona

 

3rd infusiona

Days post-1st infusion

361

364

368

375

382

431

489

 

613

618

625

632

673

688

744

IFN

IFN1

NDb

10

10

10

NDb

NDb

NDb

 

NDb

NDb

NDb

NDb

NDb

NDb

NDb

 

IFN2

NDb

NDb

NDb

NDb

NDb

NDb

NDb

 

NDb

NDb

NDb

NDb

NDb

NDb

NDb

 

IFN3

NDb

10

10

10

NDb

NDb

NDb

 

NDb

10

10

10

10

NDb

NDb

Control

C1

NDb

10

10

10

NDb

NDb

NDb

 

NDb

10

10

10

10

NDb

NDb

 

C2

NDb

20

20

20

NDb

NDb

NDb

 

NDb

10

10

10

10

NDb

NDb

 

C3

NDb

10

10

10

NDb

NDb

NDb

 

NDb

10

10

10

10

NDb

NDb